Navigation Links
Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
Date:6/18/2008

MEXICO CITY, June 18 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma" or "the Company") today announced the pricing of its initial public offering. The offering consisted of 130,869,566 series B shares; 73.5% was placed with international investors and 26.5% was placed with Mexican investors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080618/MXW007LOGO )

Excluding the overallotment option, 23.1% of the total offering size is being sold by Invex Trust No. 414 (existing shareholders) and ZN Mexico II, L.P. (one of the Nexxus family of Funds) on a pro rata basis. The shares are now listed on the Mexican Stock Exchange (ticker symbol "LAB"), and were distributed to institutional investors in the U.S. under Rule 144A and to investors outside the U.S. and elsewhere under Reg S.

The shares were offered at a price of Ps. 16 per Series B share, equivalent to US$1.54. At such price, the aggregate value of the offering is 2.4 billion pesos (2,408 millones de pesos) or approximately 233.6 million dollars, including overallotment options.

The Company's Chairman and Chief Executive Officer, Rodrigo Herrera, stated, "We are proud to be the first over-the-counter pharmaceutical and personal care products company that is traded on the Mexican Stock Exchange. This offering was successfully completed in very challenging market conditions and we thank everyone involved for their support.

"We plan to use these funds to support our rapid growth and we look forward to many years of continued expansion in the Mexican market."

Both the international offering and the local offering were well oversubscribed. Approximately 70% of the international offering was sold in the U.S. and 30% in Europe and the rest of the world. As a result of the Company's roadshow, the international book of demand was of exceptionally high quality and consisted of a combination of dedicated healthcare specialists and dedicated Latin American investors.

UBS Investment Bank was sole global coordinator of the international offering and joint bookrunner with Merrill Lynch. The lead underwriters of the Mexican offering were IXE Casa de Bolsa, S.A. de C.V., and Casa de Bolsa Santander, S.A. de C.V.

About Genomma

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico. Genomma trades on the Mexican Stock Exchange under the ticker symbol LAB.

Contact:

Maria Barona

Tel: (212) 406-3691

mbarona@i-advize.com


'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Impact of Rising Gas, Food Prices Felt Globally
2. Economy, Health Care, and Gas Prices Top Issues for Women Business Owners
3. World fertilizer prices continue to soar, scientists stress need for fertilizer efficiency
4. California Green and Organic Purchasing Strong Despite Rising Prices Says Mambo Sprouts Survey
5. Consumer Reports: Some Drug Prices Can Vary By $100 or More for the Same Bottle of Pills
6. Eat Well, Save Money: BJs Offers Everyday Low Prices on Top Quality Organic Groceries, Natural Foods Versus Supermarket Prices
7. PCMA: Skyrocketing Biotech Prices Challenge Employers, Consumers
8. MIT: Rx for high drug prices
9. NuVasive Prices $200 Million Convertible Senior Notes Due 2013
10. New Report Finds Mandatory Price Disclosure for Med Tech Would Likely Increase Prices
11. New Study Finds Slow Rate of Growth in Overall Medical Technology Prices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... ... in which the endometrial lining of the uterus spreads into the pelvic ... experiencing painful intercourse, painful periods, pelvic pain, or irregular bleeding may have ...
(Date:5/24/2017)... Massapequa Park, NY (PRWEB) , ... May 24, ... ... today announced the practice is offering holistic pediatric dentistry options for its patients ... the context of the patient’s entire physical well being, and is one of ...
(Date:5/24/2017)... ... May 24, 2017 , ... Technique, technique, technique – with a dash ... weights for strength training and exercise or simply lifting heavy objects, advises Dr. Kaliq ... is everything,” Dr. Chang says. “Improper technique in lifting anything heavy or an attempt ...
(Date:5/23/2017)... PITTSBURGH, Pa. (PRWEB) , ... May 23, 2017 , ... ... today plans to open The Alexis Joy D’Achille Center for Women’s Behavioral Health at ... state-of-the-art care available in western Pennsylvania for women suffering from pregnancy-related depression. Construction ...
(Date:5/23/2017)... , ... May 23, 2017 , ... ... technology and a 2017 Best in KLAS category winner, has named Daniel P. ... to extend and enhance its technology platform and product offerings,” says Justin Neece, ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... WASHINGTON , May 9, 2017  Demonstrating ... the board of directors for the Pharmaceutical Research ... criteria for membership. Biopharmaceutical companies will now have ... in order to be eligible to join PhRMA. ... criteria, the board is sending a clear message ...
(Date:5/6/2017)... 5, 2017   Provista , a proven leader in ... customers, today announced Jim Cunniff as the company,s ... and business experience to Provista, including most recently serving as ... California . He assumed his new role with ... great fit for Provista," says Jody Hatcher , president, ...
(Date:5/4/2017)... Clarius Mobile Health, a digital healthcare ... this week at the American Congress of Obstetricians ... San Diego, CA from May ... perfect tool for clinicians to easily confirm pregnancy, ... pregnancy-related complications like ectopic pregnancy and placenta previa," ...
Breaking Medicine Technology: